SEC FILING DETAILS

« Back

Document Details

Form
Filing Date
Mar 01, 2023
Document Date
Mar 01, 2023
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Travere Therapeutics, Inc.
Issuer
TRAVERE THERAPEUTICS, INC.